Vecuronium Bromide Injection
July 2, 2012
Bedford Laboratories has voluntarily recalled a single lot of vecuronium bromide injection 20 mg vial (NDC 55390-039-10), Lot 2067134, expiration date 5/31/2013. The affected product was shipped between August 8, 2011 and November 9, 2011. Particulate matter was found in a small number of vials and may pose a safety risk if administered to patients. Potential reactions to particulate matter include vein irritation, phlebitis, occlusion of capillaries and arteries, pulmonary granulomas, severe pulmonary dysfunction, local tissue infarction, anaphylaxis and death. As of June 28, 2012, no adverse reactions have been reported for the recalled lot.
Immediately quarantine and avoid administering the affected lot. Pharmacies and healthcare professionals must return affected product to the company. Contact Bedford Laboratories at 1-800-562-4797 (Monday to Friday, 8AM to 5PM Eastern Standard Time) with questions about the recall. Report adverse effects from the use of the recalled vecuronium bromide to FDA’s MedWatch program.
Additional information is available at the following link:
- MedWatch Alert:
- Company Press Release:
- Product Photograph:
July 2, 2012; University of Utah, Drug Information Service. Copyright 2012 Drug Information Service, University of Utah, Salt Lake City, UT.